1 Stefan Zeuzem, MD Frankfurt, Germany This activity is supported by an independent medical education grant from AbbVie, Bristol-Myers Squibb and Gilead.
Best of HCV from EASL
Daclatasvir and Sofosbuvir in Patients with Recurrent HCV Following Liver Transplantation with Advanced Fibrosis or Cirrhosis: United States Multicenter.
